E-LIB Suche - Ergebnisse für: Skibina, Olga

1

Machine-learning-based prediction of disability progression..:

De Brouwer, Edward ; Becker, Thijs ; Werthen-Brabants, Lorin...
PLOS Digital Health. 3 (2024) 7 - p. e0000533 , 2024

Link: https://doi.org/10.1371/..

2

Neutropaenia complications from Ocrelizumab and Rituximab t..:

Pang, Venus ; Seery, Nabil ; Wesselingh, Robb...
Multiple Sclerosis and Related Disorders. 81 (2024) - p. 105147 , 2024

Link: https://doi.org/10.1016/..

3

Long-term clinical outcomes in patients with multiple scler..:

Butzkueven, Helmut ; Kalincik, Tomas ; Patti, Francesco...
Therapeutic Advances in Neurological Disorders. 17 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

4

Effectiveness of cladribine compared to fingolimod, nataliz..:

Roos, Izanne ; Sharmin, Sifat ; Malpas, Charles...
Multiple Sclerosis Journal. , 2024

Link: https://doi.org/10.1177/..

5

Real-world efficacy, roll-out and uptake of intramuscular t..:

Rath, Louise ; Yeh, Wei Zhen ; Roldan, Angie...
BMJ Neurology Open. 6 (2024) 1 - p. e000667 , 2024

Link: https://doi.org/10.1136/..

6

Variability of the response to immunotherapy among subgroup..:

Diouf, Ibrahima ; Malpas, Charles B. ; Sharmin, Sifat...
European Journal of Neurology. 30 (2023) 4 - p. 1014-1024 , 2023

Link: https://doi.org/10.1111/..

7

Comparative effectiveness in multiple sclerosis: A methodol..:

Roos, Izanne ; Diouf, Ibrahima ; Sharmin, Sifat...
Multiple Sclerosis Journal. 29 (2023) 3 - p. 326-332 , 2023

Link: https://doi.org/10.1177/..

8

The risk of secondary progressive multiple sclerosis is geo..:

Sharmin, Sifat ; Roos, Izanne ; Simpson-Yap, Steve...
Brain. 146 (2023) 11 - p. 4633-4644 , 2023

Link: https://doi.org/10.1093/..

9

Predictors of treatment switching in the Big Multiple Scler..:

Spelman, Tim ; Magyari, Melinda ; Butzkueven, Helmut...
Frontiers in Neurology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

10

Early non-disabling relapses are important predictors of di..:

Daruwalla, Cyrus ; Shaygannejad, Vahid ; Ozakbas, Serkan...
Multiple Sclerosis Journal. 29 (2023) 7 - p. 875-883 , 2023

Link: https://doi.org/10.1177/..

11

Real-World Experience with Cladribine in the MSBase Registr:

Butzkueven, Helmut ; Spelman, Tim ; Hodgkinson, Suzanne...
Multiple Sclerosis and Related Disorders. 59 (2022) - p. 103619 , 2022

Link: https://doi.org/10.1016/..

12

Multiple Sclerosis Relapses Following Cessation of Fingolim..:

Malpas, Charles B. ; Roos, Izanne ; Sharmin, Sifat...
Clinical Drug Investigation. 42 (2022) 4 - p. 355-364 , 2022

Link: https://doi.org/10.1007/..

13

Prediction of relapse activity when switching to cladribine..:

Zhong, Michael ; van der Walt, Anneke ; Monif, Mastura...
Multiple Sclerosis Journal. 29 (2022) 1 - p. 119-129 , 2022

Link: https://doi.org/10.1177/..

14

Association of Latitude and Exposure to Ultraviolet B Radia..:

Vitkova, Marianna ; Diouf, Ibrahima ; Malpas, Charles...
Neurology. 98 (2022) 24 - p. , 2022

Link: https://doi.org/10.1212/..

15

Disease Reactivation After Cessation of Disease-Modifying T..:

Roos, Izanne ; Malpas, Charles ; Leray, Emmanuelle...
Neurology. 99 (2022) 17 - p. , 2022

Link: https://doi.org/10.1212/..